GGrantIndex
Sort

64,565 grants matching drug discovery

SPORE in GI Cancer

$2,300,000
Robert J Coffey · Vanderbilt University · P50 · FY2012 · CA

Washington University SPORE in Pancreatic Cancer

$2,300,000
William G Hawkins · Washington University · P50 · FY2018 · CA

Mayo Clinic Multiple Myeloma SPORE

$2,299,999
Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2017 · CA

SPORE in Bladder Cancer

$2,299,837
Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA

Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order

$2,299,669
Richard Mayeux · Columbia University Health Sciences · R01 · FY2020 · AG

National Center for Drug Discovery in Neurodegeneration

$2,299,596
Gregory D Cuny · Brigham And Women'S Hospital · U24 · FY2009 · NS

Developing a NAMPT activator for Alzheimer’s disease

$2,299,463
Beibei Chen · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AG

Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma

$2,298,636
Reynold Alexander Panettieri · Rutgers Biomedical/Health Sciences-Rbhs · P01 · FY2021 · HL

Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma

$2,298,636
Reynold Alexander Panettieri · Rutgers Biomedical And Health Sciences · P01 · FY2023 · HL

Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma

$2,298,636
Reynold Alexander Panettieri · Rutgers Biomedical And Health Sciences · P01 · FY2022 · HL

Alliance for Clinical Trials in Oncology Operations Center

$2,298,240
Monica M Bertagnolli · Brigham And Women'S Hospital · U10 · FY2019 · CA

CHEMISTRY AND BIOLOGY OF HEPARAN SULFATE

$2,298,162
Umesh Ramanlal Desai · Virginia Commonwealth University · P01 · FY2012 · HL

Xavier RCMI Center for Cancer Research

$2,297,654
Gene D'amour · Xavier University Of Louisiana · G12 · FY2017 · MD

CHEMISTRY AND BIOLOGY OF HEPARAN SULFATE

$2,297,262
Umesh Ramanlal Desai · Virginia Commonwealth University · P01 · FY2017 · HL

NIMH Psychoactive Drug Screening Program

$2,297,124
Bryan L Roth · Univ Of North Carolina Chapel Hill · N01 · FY2012 · MH

Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery

$2,297,118
Colleen B Jonsson · University Of Tennessee Health Sci Ctr · UC7 · FY2023 · AI

Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor

$2,295,562
Lei Shi · National Institute On Drug Abuse · ZIA · FY2025 · DA

CHEMISTRY AND BIOLOGY OF HEPARAN SULFATE

$2,295,423
Umesh Ramanlal Desai · Virginia Commonwealth University · P01 · FY2016 · HL

SPORE in Breast Cancer

$2,295,384
Olufunmilayo I Olopade · University Of Chicago · P50 · FY2006 · CA

Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order

$2,293,547
Richard Mayeux · Columbia University Health Sciences · R01 · FY2021 · AG

Harvard-wide Program on Antibiotic Resistance

$2,292,953
Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2023 · AI

Screening for a Drug for Sickle Cell Disease

$2,291,933
William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

The Psychophysiology of Fear and Anxiety

$2,291,326
Christian Grillon · National Institute Of Mental Health · ZIA · FY2018 · MH

Novel Molecular Mechanisms Promote GPCR-Induced Bronchodilation in Asthma

$2,290,948
Reynold Alexander Panettieri · Rutgers Biomedical/Health Sciences-Rbhs · P01 · FY2020 · HL

Innovative Strategies to Combat Antibiotic-resistant Infections

$2,290,304
Scott J Hultgren · Washington University · U19 · FY2023 · AI